Suwon-si, South Korea

Xiangai Gui

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Xiangai Gui in Biotech

Introduction

Xiangai Gui is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the study of botulinum toxin. With a total of five patents to his name, his work has garnered attention for its innovative approaches and methodologies.

Latest Patents

Among his latest patents is a cell-based method for determining the activity of botulinum toxin. This patent introduces a new cell line and an antibody specifically designed for this purpose. The method disclosed allows for the determination of the activity of botulinum toxin using the newly developed cell line and/or the antibody. This innovation is crucial for advancing research and applications related to botulinum toxin.

Career Highlights

Xiangai Gui is currently associated with Hugel Inc., where he continues to push the boundaries of research in biotechnology. His work has not only contributed to scientific knowledge but also has practical implications in various industries.

Collaborations

Xiangai has collaborated with notable colleagues, including Chee Gun Lee and Ji Hyun Oum. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Xiangai Gui's contributions to biotechnology, particularly in the area of botulinum toxin research, highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to developing effective methods that can benefit various applications in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…